These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 27112703)

  • 21. The investigation of a prolonged APTT with specific clotting factor assays is unnecessary if an APTT with Actin FS is normal.
    Bowyer A; Smith J; Woolley AM; Kitchen S; Hampton KK; Maclean RM; VAN Veen JJ; Makris M
    Int J Lab Hematol; 2011 Apr; 33(2):212-8. PubMed ID: 20880301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies.
    Livnat T; Tamarin I; Mor Y; Winckler H; Horowitz Z; Korianski Y; Bar-Zakay B; Seligsohn U; Salomon O
    Thromb Haemost; 2009 Sep; 102(3):487-92. PubMed ID: 19718468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe factor XI deficiency caused by a Gly555 to Glu mutation (factor XI-Glu555): a cross-reactive material positive variant defective in factor IX activation.
    Zivelin A; Ogawa T; Bulvik S; Landau M; Toomey JR; Lane J; Seligsohn U; Gailani D
    J Thromb Haemost; 2004 Oct; 2(10):1782-9. PubMed ID: 15456490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Congenital factor XI deficiency in a domestic shorthair cat.
    Troxel MT; Brooks MB; Esterline ML
    J Am Anim Hosp Assoc; 2002; 38(6):549-53. PubMed ID: 12428887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitoring low dose recombinant factor VIIa therapy in patients with severe factor XI deficiency undergoing surgery.
    Riddell A; Abdul-Kadir R; Pollard D; Tuddenham E; Gomez K
    Thromb Haemost; 2011 Sep; 106(3):521-7. PubMed ID: 21833443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coagulation factor XI as a novel target for antithrombotic treatment.
    Löwenberg EC; Meijers JC; Monia BP; Levi M
    J Thromb Haemost; 2010 Nov; 8(11):2349-57. PubMed ID: 20727068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of a severe factor XI deficiency in patient undergoing hemodialysis without the use of heparin.
    Takamizawa Y; Araki M; Yoshida N; Yoshioka T; Miura K
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):898-9. PubMed ID: 24914741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice.
    Wang X; Cheng Q; Xu L; Feuerstein GZ; Hsu MY; Smith PL; Seiffert DA; Schumacher WA; Ogletree ML; Gailani D
    J Thromb Haemost; 2005 Apr; 3(4):695-702. PubMed ID: 15733058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prerequisites for recombinant factor VIIa-induced thrombin generation in plasmas deficient in factors VIII, IX or XI.
    Livnat T; Zivelin A; Martinowitz U; Salomon O; Seligsohn U
    J Thromb Haemost; 2006 Jan; 4(1):192-200. PubMed ID: 16409469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel factor XI missense mutation (Val371Ile) in the activation loop is responsible for a case of mild type II factor XI deficiency.
    Bozzao C; Rimoldi V; Asselta R; Landau M; Ghiotto R; Tenchini ML; De Cristofaro R; Castaman G; Duga S
    FEBS J; 2007 Dec; 274(23):6128-38. PubMed ID: 17971173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquired factor XI deficiency: a rare complication after liver transplantation.
    Yankol Y; Mecit N; Kanmaz T; Acarli K; Kalayoglu M
    Transplant Proc; 2015; 47(1):179-81. PubMed ID: 25596963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bleeding phenotype and correlation with factor XI (FXI) activity in congenital FXI deficiency: results of a retrospective study from a single centre.
    Santoro C; Di Mauro R; Baldacci E; De Angelis F; Abbruzzese R; Barone F; Bochicchio RA; Ferrara G; Guarini A; Foà R; Mazzucconi MG
    Haemophilia; 2015 Jul; 21(4):496-501. PubMed ID: 25623511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Factor XI inhibitors : clinical and biological features].
    Billon S; Blouch MT; Escoffre-Barbe M; Niger CL; Abgrall JF; Roux AM
    Ann Biol Clin (Paris); 2001; 59(2):183-6. PubMed ID: 11282522
    [No Abstract]   [Full Text] [Related]  

  • 34. Acquired haemophilia A: errors in the diagnosis.
    Kazmi MA; Pickering W; Smith MP; Holland LJ; Savidge GF
    Blood Coagul Fibrinolysis; 1998 Oct; 9(7):623-8. PubMed ID: 9863711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simple and accurate microplate assay for the determination of factor XI in plasma.
    Scott CF; Colman RW
    J Lab Clin Med; 1988 Jun; 111(6):708-14. PubMed ID: 3373114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Artificial deficient plasma for the determination of the activity of coagulation factor XI].
    Lutze G; Dieckmann U; Urbahn H
    Z Med Lab Diagn; 1984; 25(8):427-31. PubMed ID: 6523998
    [No Abstract]   [Full Text] [Related]  

  • 37. [The inherited coagulation factor XI deficiency caused by intronic mutation IVS J-4delgttg].
    Xie S; Wang HL; Wang XF; Wu WM; Zhou RF; Wang WB; Hu YQ; Wang ZY
    Zhonghua Xue Ye Xue Za Zhi; 2005 Mar; 26(3):144-7. PubMed ID: 15946525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Definition of the population at risk of bleeding due to factor XI deficiency in Ashkenazic Jews and the value of activated partial thromboplastin time in its detection.
    Seligsohn U; Modan M
    Isr J Med Sci; 1981 Jun; 17(6):413-5. PubMed ID: 7263201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro evaluation of factor IX as novel treatment for factor XI deficiency.
    Bakhtiari K; Meijers JCM
    Blood; 2019 Aug; 134(6):573-575. PubMed ID: 31126917
    [No Abstract]   [Full Text] [Related]  

  • 40. Congenital factor XI deficiency: an update.
    Duga S; Salomon O
    Semin Thromb Hemost; 2013 Sep; 39(6):621-31. PubMed ID: 23929304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.